Substance use disorders assessed using the Kreek-McHugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patients

American Journal on Addictions

Volumn 20, Issue 3, 2011, Pages 292-299

  Tang, Yi Lang ^a   Khoury, Lamya ^a   Bradley, Bekh ^a,b   Gillespie, Charles F ^a   Ressler, Kerry J ^a,c,d   Cubells, Joseph F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEROIN DEPENDENCE; HUMAN; KREEK MCHUGH SCHLUGER KELLOGG SCALE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT CARE; PRIMARY MEDICAL CARE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; URBAN AREA;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; POVERTY; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION;

EID: 79954417593     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00121.x     Document Type: Article

References (30)

1. Kessler RC, Chiu WT, Demler O, et al,. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62: 617-627. (Pubitemid 40973437)
2. Degenhardt L, Chiu WT, Sampson N, et al,. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Med. 2008; 5: e141.
3. Kessler RC, McGonagle KA, Zhao S, et al,. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51: 8-19. (Pubitemid 24028993)
4. Kessler RC., The epidemiology of dual diagnosis. Biol Psychiatry. 2004; 56: 730-737. (Pubitemid 39539830)
5. Glantz MD, Anthony JC, Berglund PA, et al,. Mental disorders as risk factors for later substance dependence: Estimates of optimal prevention and treatment benefits. Psychol Med. 2009; 39: 1365-1377.
6. Merikangas KR, Mehta RL, Molnar BE, et al,. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 1998; 23: 893-907. (Pubitemid 28443200)
7. Dickey B, Normand SL, Weiss RD, et al,. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002; 53: 861-867. (Pubitemid 34742769)
8. Martino S, Grilo CM, Fehon DC,. Development of the drug abuse screening test for adolescents (DAST-A). Addict Behav. 2000; 25: 57-70. (Pubitemid 30055259)
9. Skinner HA., The drug abuse screening test. Addict Behav. 1982; 7: 363-371. (Pubitemid 13162181)
10. Vazquez FL, Blanco V, Lopez M,. Performance of a new substance dependence screening questionnaire (SDSQ) in a non-clinical population. Addict Behav. 2007; 32: 1082-1087.
11. Mayfield D, McLeod G, Hall P,. The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry. 1974; 131: 1121-1123.
12. Elvy GA, Wells JE,. The Canterbury alcoholism screening test (CAST): A detection instrument for use with hospitalised patients. N Z Med J. 1984; 97: 111-115. (Pubitemid 14149651)
13. Bohn MJ, Babor TF, Kranzler HR,. The alcohol use disorders identification test (AUDIT): Validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995; 56: 423-432.
14. Kellogg SH, McHugh PF, Bell K, et al,. The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend. 2003; 69: 137-150. (Pubitemid 36259776)
15. Proudnikov D, Hamon S, Ott J, et al,. Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction. Neurosci Lett. 2008; 435: 234-239.
16. Levran O, Londono D, O'Hara K, et al,. Genetic susceptibility to heroin addiction: A candidate gene association study. Genes Brain Behav. 2008; 7: 720-729.
17. Mitchell JM, Fields HL, White RL, et al,. The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers. J Clin Psychopharmacol. 2007; 27: 112-115.
18. First M, Spitzer R, Gibbon M, et al,. Stuctured Clinical Interview for Axis I DSM-IV-TR Axis I Disorders: Non-patient Edition (SCID-I/NP, 11/2002 revision). New York: Biometrics Research Department, New York State Psychiatric Institute; 2002.
19. Binder EB, Bradley RG, Liu W, et al,. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA. 2008; 299: 1291-1305. (Pubitemid 351439075)
20. Bradley RG, Binder EB, Epstein MP, et al,. Influence of child abuse on adult depression: Moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry. 2008; 65: 190-200. (Pubitemid 351214318)
21. Gillespie CF, Bradley B, Mercer K, et al,. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry. 2009; 31: 505-514.
22. Baldessarini RJ, Finklestein S, Arana GW,. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry. 1983; 40: 569-573. (Pubitemid 13079450)
23. Murphy JM, Berwick DM, Weinstein MC, et al,. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry. 1987; 44: 550-555. (Pubitemid 17082096)
24. McFall RM, Treat TA,. Quantifying the information value of clinical assessments with signal detection theory. Annu Rev Psychol. 1999; 50: 215-241.
25. Gavin DR, Ross HE, Skinner HA,. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict. 1989; 84: 301-307. (Pubitemid 19123352)
26. Ross HE, Gavin DR, Skinner HA,. Diagnostic validity of the MAST and the alcohol dependence scale in the assessment of DSM-III alcohol disorders. J Stud Alcohol. 1990; 51: 506-513.
27. Bradley KA, Boyd-Wickizer J, Powell SH, et al,. Alcohol screening questionnaires in women: A critical review. JAMA. 1998; 280: 166-171. (Pubitemid 28498390)
28. Olden M, Rosenfeld B, Pessin H, et al,. Measuring depression at the end of life: Is the Hamilton Depression Rating Scale a valid instrument? Assessment. 2009; 16: 43-54.
29. Bucholz KK, Cadoret R, Cloninger CR, et al,. A new, semi-structured psychiatric interview for use in genetic linkage studies: A report on the reliability of the SSAGA. J Stud Alcohol. 1994; 55: 149-158. (Pubitemid 24080088)
30. Pierucci-Lagha A, Gelernter J, Feinn R, et al,. Diagnostic reliability of the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend. 2005; 80: 303-312. (Pubitemid 41660851)